N-acetylcysteine in cardiac surgery: Do the benefits outweigh the risks? A meta-analytic reappraisal

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 25, Issue 2, 2011, Pages 268-275

  Wang, Guyan ^a   Bainbridge, Daniel ^b   Martin, Janet ^b   Cheng, Davy ^b  

^a PEKING UNION MEDICAL COLLEGE   (China)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; CREATININE; INOTROPIC AGENT; PLACEBO;

ACUTE HEART INFARCTION; ACUTE KIDNEY FAILURE; AORTA BALLOON; ARTICLE; ARTIFICIAL VENTILATION; CREATININE BLOOD LEVEL; ERYTHROCYTE TRANSFUSION; HEART ATRIUM FIBRILLATION; HEART SURGERY; HUMAN; INFECTION; INTENSIVE CARE UNIT; LENGTH OF STAY; META ANALYSIS; MORBIDITY; MORNING DOSAGE; MORTALITY; NAUSEA AND VOMITING; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RENAL REPLACEMENT THERAPY; RISK BENEFIT ANALYSIS; SECOND LOOK SURGERY; STROKE; SYSTEMATIC REVIEW; TREATMENT DURATION; VOMITING;

ACETYLCYSTEINE; CARDIAC SURGICAL PROCEDURES; FREE RADICAL SCAVENGERS; HUMANS; POSTOPERATIVE COMPLICATIONS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK ASSESSMENT; RISK FACTORS;

EID: 79954415729     PISSN: 10530770     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jvca.2010.04.022     Document Type: Article

References (36)

1. Birck R, Krzossok S, Markowetz F, et al: Acetylcysteine for prevention of contrast nephropathy: Meta-analysis. Lancet 362:598-603, 2003 (Pubitemid 37013299)
2. Kelly AM, Dwamena B, Cronin P, et al: Meta-analysis: Effectiveness of drugs for preventing contrast-induced nephropathy. Ann Intern Med 148:284-294, 2008 (Pubitemid 351665489)
3. Barr LF, Kolodner K: N-acetylcysteine and fenoldopam protect the renal function of patients with chronic renal insufficiency undergoing cardiac surgery. Crit Care Med 36:1427-1435, 2008 (Pubitemid 351620648)
4. Fischer UM, Tossios P, Mehlhorn U: Renal protection by radical scavenging in cardiac surgery patients. Curr Med Res Opin 21:1161-1164, 2005
5. Adabag AS, Ishani A, Koneswaran S, et al: Utility of N-acetylcysteine to prevent acute kidney injury after cardiac surgery: A randomized controlled trial. Am Heart J 155:1143-1149, 2008
6. Burns KE, Chu MW, Novick RJ, et al: Perioperative N-acetylcysteine to prevent renal dysfunction in high-risk patients undergoing cabg surgery: A randomized controlled trial. JAMA 294:342-350, 2005 (Pubitemid 41043778)
7. Haase M, Haase-Fielitz A, Bagshaw SM, et al: Phase II, randomized, controlled trial of high-dose N-acetylcysteine in high-risk cardiac surgery patients. Crit Care Med 35:1324-1331, 2007 (Pubitemid 46642662)
8. Ristikankare A, Kuitunen T, Kuitunen A, et al: Lack of renoprotective effect of IV N-acetylcysteine in patients with chronic renal failure undergoing cardiac surgery. Br J Anaesth 97:611-616, 2006 (Pubitemid 44593854)
9. Wijeysundera DN, Beattie WS, Rao V, et al: N-acetylcysteine for preventing acute kidney injury in cardiac surgery patients with preexisting moderate renal insufficiency. Can J Anaesth 54:872-881, 2007 (Pubitemid 350206604)
10. Adabag AS, Ishani A, Bloomfield HE, et al: Efficacy of N-acetylcysteine in preventing renal injury after heart surgery: A systematic review of randomized trials. Eur Heart J 30:1910-1917, 2009
11. Naughton F, Wijeysundera D, Karkouti K, et al: N-acetylcysteine to reduce renal failure after cardiac surgery: A systematic review and meta-analysis. Can J Anaesth 55:827-835, 2008
12. Nigwekar SU, Kandula P: N-acetylcysteine in cardiovascularsurgery- associated renal failure: A meta-analysis. Ann Thorac Surg 87:139-147, 2009
13. Ho KM, Morgan DJ: Meta-analysis of N-acetylcysteine to prevent acute renal failure after major surgery. Am J Kidney Dis 53:33-40, 2009
14. Wijeysundera DN, Karkouti K, Rao V, et al: N-acetylcysteine is associated with increased blood loss and blood product utilization during cardiac surgery. Crit Care Med 37:1929-1934, 2009
15. Ozaydin M, Peker O, Erdogan D, et al: N-acetylcysteine for the prevention of postoperative atrial fibrillation: A prospective, randomized, placebo-controlled pilot study. Eur Heart J 29:625-631, 2008
16. Baker WL, Anglade MW, Baker EL, et al: Use of N-acetylcysteine to reduce post-cardiothoracic surgery complications: A metaanalysis. Eur J Cardiothorac Surg 35:521-527, 2009
17. El-Hamamsy I, Stevens LM, Carrier M, et al: Effect of intravenous N-acetylcysteine on outcomes after coronary artery bypass surgery: A randomized, double-blind, placebo-controlled clinical trial. J Thorac Cardiovasc Surg 133:7-12, 2007 (Pubitemid 46014198)
18. Eren N, Cakir O, Oruc A, et al: Effects of N-acetylcysteine on pulmonary function in patients undergoing coronary artery bypass surgery with cardiopulmonary bypass. Perfusion 18:345-350, 2003 (Pubitemid 38072318)
19. Sisillo E, Ceriani R, Bortone F, et al: N-acetylcysteine for prevention of acute renal failure in patients with chronic renal insufficiency undergoing cardiac surgery: A prospective, randomized, clinical trial. Crit Care Med 36:81-86, 2008
20. Sucu N, Cinel I, Unlu A, et al: N-acetylcysteine for preventing pump-induced oxidoinflammatory response during cardiopulmonary bypass. Surg Today 34:237-242, 2004 (Pubitemid 38315338)
21. Moher D, Cook DJ, Eastwood S, et al: Improving the quality of reports of meta-analyses of randomised controlled trials: The QUOROM statement. Quality of reporting of meta-analyses. Lancet 354:1896-1900, 1999
22. Jadad AR, Moore RA, Carroll D, et al: Assessing the quality of reports of randomized clinical trials: Is blinding necessary? Control Clin Trials 17:1-12, 1996
23. Higgins JP, Thompson SG: Quantifying heterogeneity in a metaanalysis. Stat Med 21:1539-1558, 2002
24. Higgins JP, Thompson SG, Deeks JJ, et al: Measuring inconsistency in meta-analyses. BMJ 327:557-560, 2003 (Pubitemid 37088507)
25. DerSimonian R, Laird N: Meta-analysis in clinical trials. Control Clin Trials 7:177-188, 1986 (Pubitemid 17189972)
26. Egger M, Davey Smith G, Schneider M, et al: Bias in metaanalysis detected by a simple, graphical test. BMJ 315:629-634, 1997 (Pubitemid 27387172)
27. Fischer UM, Tossios P, Huebner A, et al: Myocardial apoptosis prevention by radical scavenging in patients undergoing cardiac surgery. J Thorac Cardiovasc Surg 128:103-108, 2004
28. Orhan G, Yapici N, Yuksel M, et al: Effects of N-acetylcysteine on myocardial ischemia-reperfusion injury in bypass surgery. Heart Vessels 21:42-47, 2006 (Pubitemid 43174290)
29. Peker O, Peker T, Erdogan D, et al: Effects of intravenous N-acetylcysteine on periprocedural myocardial injury after on-pump coronary artery by-pass grafting. J Cardiovasc Surg (Torino) 49:527-531, 2008
30. Tossios P, Bloch W, Huebner A, et al: N-acetylcysteine prevents reactive oxygen species-mediated myocardial stress in patients undergoing cardiac surgery: Results of a randomized, double-blind, placebo-controlled clinical trial. J Thorac Cardiovasc Surg 126:1513-1520, 2003 (Pubitemid 37449181)
31. Zhu J, Yin R, Shao H, et al: N-acetylcysteine to ameliorate acute renal injury in a rat cardiopulmonary bypass model. J Thorac Cardiovasc Surg 133:696-703, 2007
32. DiMari J, Megyesi J, Udvarhelyi N, et al: N-acetylcysteine ameliorates ischemic renal failure. Am J Physiol 272:F292-F298, 1997
33. Bellomo R, Auriemma S, Fabbri A, et al: The pathophysiology of cardiac surgery-associated acute kidney injury (CSA-AKI). Int J Artif Organs 31:166-178, 2008 (Pubitemid 351425014)
34. Rosner MH, Portilla D, Okusa MD: Cardiac surgery as a cause of acute kidney injury: Pathogenesis and potential therapies. J Intensive Care Med 23:3-18, 2008
35. Niemi TT, Munsterhjelm E, Poyhia R, et al: The effect of N-acetylcysteine on blood coagulation and platelet function in patients undergoing open repair of abdominal aortic aneurysm. Blood Coagul Fibrinolysis 17:29-34, 2006 (Pubitemid 43170751)
36. Peake SL, Moran JL, Leppard PI: N-acetyl-L-cysteine depresses cardiac performance in patients with septic shock. Crit Care Med 24:1302-1310, 1996 (Pubitemid 26262402)